Antibiotic resistance acquired through a DNA damage-inducible response in Acinetobacter baumannii

Journal of Bacteriology

Volumn 195, Issue 6, 2013, Pages 1335-1345

  Norton, Matthew D ^a   Spilkia, Allison J ^a   Godoy, Veronica G ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA POLYMERASE; MESYLIC ACID METHYL ESTER;

ACINETOBACTER BAUMANNII; ALKYLATION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DESICCATION; DNA DAMAGE; ESCHERICHIA COLI; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PRIORITY JOURNAL; RECA GENE; ULTRAVIOLET RADIATION;

ACINETOBACTER BAUMANNII; ADENOSINE TRIPHOSPHATASES; ALKYLATION; BACTERIAL PROTEINS; DESICCATION; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE KNOCKOUT TECHNIQUES; MUTATION; REC A RECOMBINASES; RIFAMPIN; SOS RESPONSE (GENETICS); ULTRAVIOLET RAYS;

EID: 84874682458     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.02176-12     Document Type: Article

References (82)

1. Bergogne-Berezin E, Friedman H, Bendinelli M. 2008. Acinetobacter biology and pathogenesis, vol xvi. Springer-Verlag, New York, NY.
2. Gerischer U. 2008. Acinetobacter molecular biology. Caister Academic Press, Norfolk, United Kingdom.
3. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. 1998. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J. Clin. Microbiol. 36:1938-1941.
4. Kramer A, Schwebke I, Kampf G. 2006. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect. Dis. 6:130.
5. Neely AN. 2000. A survey of gram-negative bacteria survival on hospital fabrics and plastics. J. Burn Care Rehab. 21:523-527.
6. Neely AN, Maley MP, Warden GD. 1999. Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. Clin. Infect. Dis. 29:1358-1360.
7. Wendt C, Dietze B, Dietz E, Ruden H. 1997. Survival of Acinetobacter baumannii on dry surfaces. J. Clin. Microbiol. 35:1394-1397.
8. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV. 2007. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J. Clin. Microbiol. 45:3352-3359.
9. Bergogne-Berezin E. 1995. The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents. J. Hosp. Infect. 30(Suppl):441-452.
10. Bergogne-Berezin E. 2001. The increasing role of Acinetobacter species as nosocomial pathogens. Curr. Infect. Dis. Rep. 3:440-444.
11. Bergogne-Berezin E, Joly-Guillou ML. 1991. Hospital infection with Acinetobacter spp.: an increasing problem. J. Hosp. Infect. 18(Suppl A): 250-255.
12. Bergogne-Berezin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
13. Vila J, Marti S, Sanchez-Cespedes J. 2007. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 59:1210-1215.
14. Snitkin ES, Zelazny AM, Montero CI, Stock F, Mijares L, Murray PR, Segre JA. 2011. Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc. Natl. Acad. Sci. U. S. A. 108:13758-13763.
15. Cirz RT, Romesberg FE. 2007. Controlling mutation: intervening in evolution as a therapeutic strategy. Crit. Rev. Biochem. Mol. Biol. 42:341-354.
16. Petrosino JF, Galhardo RS, Morales LD, Rosenberg SM. 2009. Stressinduced beta-lactam antibiotic resistance mutation and sequences of stationary-phase mutations in the Escherichia coli chromosome. J. Bacteriol. 191:5881-5889.
17. Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellenberger T. 2006. DNA repair and mutagenesis, 2nd ed. ASM Press, Washington, DC.
18. Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H, Cohen SN. 2004. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305:1629-1631.
19. Courcelle J, Khodursky A, Peter B, Brown PO, Hanawalt PC. 2001. Comparative gene expression profiles followingUVexposure in wild-type and SOS-deficient Escherichia coli. Genetics 158:41-64.
20. Galhardo RS, Hastings PJ, Rosenberg SM. 2007. Mutation as a stress response and the regulation of evolvability. Crit. Rev. Biochem. Mol. Biol. 42:399-435.
21. Sutton MD, Smith BT, Godoy VG, Walker GC. 2000. The SOS response: recent insights into umuDC-dependent mutagenesis and DNA damage tolerance. Annu. Rev. Genet. 34:479-497.
22. Kogoma T. 1997. Stable DNA replication: interplay between DNA replication, homologous recombination, and transcription. Microbiol. Mol. Biol. Rev. 61:212-238.
23. Kelley WL. 2006. Lex marks the spot: the virulent side of SOS and a closer look at the LexA regulon. Mol. Microbiol. 62:1228-1238.
24. Dorr T, Lewis K, Vulic M. 2009. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet. 5:e1000760.
25. Godoy VG, Jarosz DF, Walker FL, Simmons LA, Walker GC. 2006. Y-family DNA polymerases respond to DNA damage-independent inhibition of replication fork progression. EMBO J. 25:868-879.
26. Kowalczykowski SC, Dixon DA, Eggleston AK, Lauder SD, Rehrauer WM. 1994. Biochemistry of homologous recombination in Escherichia coli. Microbiol. Rev. 58:401-465.
27. Godoy VG, Jarosz DF, Simon SM, Abyzov A, Ilyin V, Walker GC. 2007. UmuD and RecA directly modulate the mutagenic potential of the Y family DNA polymerase DinB. Mol. Cell 28:1058-1070.
28. Rehrauer WM, Bruck I, Woodgate R, Goodman MF, Kowalczykowski SC. 1998. Modulation of RecA nucleoprotein function by the mutagenic UmuD'C protein complex. J. Biol. Chem. 273:32384-32387.
29. Tang M, Bruck I, Eritja R, Turner J, Frank EG, Woodgate R, O'Donnell M, Goodman MF. 1998. Biochemical basis of SOS-induced mutagenesis in Escherichia coli: reconstitution of in vitro lesion bypass dependent on the UmuD'2C mutagenic complex and RecA protein. Proc. Natl. Acad. Sci. U. S. A. 95:9755-9760.
30. Aranda J, Bardina C, Beceiro A, Rumbo S, Cabral MP, Barbe J, Bou G. 2011. Acinetobacter baumannii RecA protein in repair of DNA damage, antimicrobial resistance, general stress response, and virulence. J. Bacteriol. 193:3740-3747.
31. Hare JM, Perkins SN, Gregg-Jolly LA. 2006. A constitutively expressed, truncated umuDC operon regulates the recA-dependent DNA damage induction of a gene in Acinetobacter baylyi strain ADP1. Appl. Environ. Microbiol. 72:4036-4043.
32. Rauch PJ, Palmen R, Burds AA, Gregg-Jolly LA, van der Zee JR, Hellingwerf KJ. 1996. The expression of the Acinetobacter calcoaceticus recA gene increases in response to DNA damage independently of RecA and of development of competence for natural transformation. Microbiology 142(Pt 4):1025-1032.
33. Robinson A, Brzoska AJ, Turner KM, Withers R, Harry EJ, Lewis PJ, Dixon NE. 2010. Essential biological processes of an emerging pathogen: DNA replication, transcription, and cell division in Acinetobacter spp. Microbiol. Mol. Biol. Rev. 74:273-297.
34. Yang W. 2011. Surviving the sun: repair and bypass of DNA UV lesions. Protein Sci. 20:1781-1789.
35. Beuning PJ, Simon SM, Godoy VG, Jarosz DF, Walker GC. 2006. Characterization of Escherichia coli translesion synthesis polymerases and their accessory factors. Methods Enzymol. 408:318-340.
36. Fuchs RP, Fujii S, Wagner J. 2004. Properties and functions of Escherichia coli: Pol IV and Pol V. Adv. Protein Chem. 69:229-264.
37. Ling H, Boudsocq F, Woodgate R, Yang W. 2001. Crystal structure of a Y-family DNA polymerase in action: a mechanism for error-prone and lesion-bypass replication. Cell 107:91-102.
38. Yang W, Woodgate R. 2007. What a difference a decade makes: insights into translesion DNA synthesis. Proc. Natl. Acad. Sci. U. S. A. 104:15591-15598.
39. Maor-Shoshani A, Reuven NB, Tomer G, Livneh Z. 2000. Highly mutagenic replication byDNApolymeraseV(UmuC) provides a mechanistic basis for SOS untargeted mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 97: 565-570.
40. Reuven NB, Tomer G, Livneh Z. 1998. The mutagenesis proteins UmuD' and UmuC prevent lethal frameshifts while increasing base substitution mutations. Mol. Cell 2:191-199.
41. Seward RJ, Towner KJ. 1998. Molecular epidemiology of quinolone resistance in Acinetobacter spp. Clin. Microbiol. Infect. 4:248-254.
42. Vila J, Ruiz J, Goni P, Jimenez de Anta T. 1997. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J. Antimicrob. Chemother. 39:757-762.
43. Vila J, Ruiz J, Goni P, Marcos A, Jimenez de Anta T. 1995. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 39:1201-1203.
44. Ohmori H, Friedberg EC, Fuchs RP, Goodman MF, Hanaoka F, Hinkle D, Kunkel TA, Lawrence CW, Livneh Z, Nohmi T, Prakash L, Prakash S, Todo T, Walker GC, Wang Z, Woodgate R. 2001. The Y-family of DNA polymerases. Mol. Cell 8:7-8.
45. Di Nocera PP, Rocco F, Giannouli M, Triassi M, Zarrilli R. 2011. Genome organization of epidemic Acinetobacter baumannii strains. BMC Microbiol. 11:224.
46. Hare J, Bradley J, Lin CL, Elam T. 2012. Diverse responses to UV light exposure in Acinetobacter include the capacity for DNA damage-induced mutagenesis in the opportunistic pathogens Acinetobacter baumannii and Acinetobacter ursingii. Microbiology 158(Pt 3):601-611.
47. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, Snyder M. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21:601-614.
48. Schaub IG, Hauber FD. 1948. A biochemical and serological study of a group of identical unidentifiable gram-negative bacilli from human sources. J. Bacteriol. 56:379-385.
49. Amsterdam D. 1996. Susceptibility testing of antimicrobials in liquid media, p 52-111. In Lorian V (ed), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, MD.
50. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
51. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
52. Zaslaver A, Bren A, Ronen M, Itzkovitz S, Kikoin I, Shavit S, Liebermeister W, Surette MG, Alon U. 2006. A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat. Methods 3:623-628.
53. Ausubel FM. 1994. Current protocols in molecular biology. John Wiley & Sons, Inc., Brooklyn, NY.
54. Giannouli M, Di Popolo A, Durante-Mangoni E, Bernardo M, Cuccurullo S, Amato G, Tripodi MF, Triassi M, Utili R, Zarrilli R. 2012. Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy. Int. J. Antimicrob. Agents 39:58-63.
55. Nohmi T. 2006. Environmental stress and lesion-bypass DNA polymerases. Annu. Rev. Microbiol. 60:231-253.
56. Tang WJ. 1993. Blot-affinity purification of antibodies. Methods Cell Biol. 37:95-104.
57. Woodgate R, Rajagopalan M, Lu C, Echols H. 1989. UmuC mutagenesis protein of Escherichia coli: purification and interaction with UmuD and UmuD'. Proc. Natl. Acad. Sci. U. S. A. 86:7301-7305.
58. Boudsocq F, Ling H, Yang W, Woodgate R. 2002. Structure-based interpretation of missense mutations in Y-family DNA polymerases and their implications for polymerase function and lesion bypass.DNARepair (Amst.) 1:343-358.
59. Hare JM, Adhikari S, Lambert KV, Hare AE, Grice AN. 14 June 2012. The Acinetobacter regulatory UmuDAb protein cleaves in response to DNA damage with chimeric LexA/UmuD characteristics. FEMS Microbiol. Lett. [Epub ahead of print.]
60. Markham BE, Harper JE, Mount DW, Sancar GB, Sancar A, Rupp WD, Kenyon CJ, Walker GC. 1984. Analysis of mRNA synthesis following induction of the Escherichia coli SOS system. J. Mol. Biol. 178:237-248.
61. Bjedov I, Dasgupta CN, Slade D, Le Blastier S, Selva M, Matic I. 2007. Involvement of Escherichia coli DNA polymerase IV in tolerance of cytotoxic alkylating DNA lesions in vivo. Genetics 176:1431-1440.
62. Benson RW, Norton MD, Lin I, Du Comb WS, Godoy VG. 2011. An active site aromatic triad in Escherichia coli DNA Pol IV coordinates cell survival and mutagenesis in different DNA damaging agents. PLoS One 6:e19944.
63. Malik M, Zhao X, Drlica K. 2006. Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones. Mol. Microbiol. 61:810-825.
64. Schlacher K, Goodman MF. 2007. Lessons from 50 years of SOS DNAdamage-induced mutagenesis. Nat. Rev. Mol. Cell Biol. 8:587-594.
65. Garibyan L, Huang T, Kim M, Wolff E, Nguyen A, Nguyen T, Diep A, Hu K, Iverson A, Yang H, Miller JH. 2003. Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair (Amst.) 2:593-608.
66. Potts M. 1994. Desiccation tolerance of prokaryotes. Microbiol. Rev. 58: 755-805.
67. Li B, Smith P, Horvath DJ, Jr, Romesberg FE, Justice SS. 2010. SOS regulatory elements are essential for UPEC pathogenesis. Microbes Infect. 12:662-668.
68. Jarosz DF, Godoy VG, Delaney JC, Essigmann JM, Walker GC. 2006. A single amino acid governs enhanced activity of DinBDNApolymerases on damaged templates. Nature 439:225-228.
69. Jarosz DF, Godoy VG, Walker GC. 2007. Proficient and accurate bypass of persistent DNA lesions by DinB DNA polymerases. Cell Cycle 6:817-822.
70. Davis EO, Springer B, Gopaul KK, Papavinasasundaram KG, Sander P, Bottger EC. 2002. DNA damage induction of recA in Mycobacterium tuberculosis independently of RecA and LexA. Mol. Microbiol. 46:791-800.
71. Yasbin RE, Cheo DL, Bayles KW. 1992. Inducible DNA repair and differentiation in Bacillus subtilis: interactions between global regulons. Mol. Microbiol. 6:1263-1270.
72. Botzenhart K, Ruden H, Tolon M, von Scharfenberg KM. 1976. Clinical uses of ultraviolet light radiation. Prakt. Anaesth. 11:320-327. (In German.)
73. Hart D. 1960. Bactericidal ultraviolet radiation in the operating room. Twenty-nine-year study for control of infections. JAMA 172:1019-1028.
74. Riley RL, Kaufman JE. 1971. Air disinfection in corridors by upper air irradiation with ultraviolet. Arch. Environ. Health 22:551-553.
75. Riley RL, Nardell EA. 1989. Clearing the air. The theory and application of ultraviolet air disinfection. Am. Rev. Respir. Dis. 139:1286-1294.
76. Sexton JZ, Wigle TJ, He Q, Hughes MA, Smith GR, Singleton SF, Williams AL, Yeh LA. 2010. Novel inhibitors of E. coli RecA ATPase activity. Curr. Chem. Genomics 4:34-42.
77. Wigle TJ, Sexton JZ, Gromova AV, Hadimani MB, Hughes MA, Smith GR, Yeh LA, Singleton SF. 2009. Inhibitors of RecA activity discovered by high-throughput screening: cell-permeable small molecules attenuate the SOS response in Escherichia coli. J. Biomol. Screen. 14:1092-1101.
78. Romesberg F, David NE, Cirz R. May 2009. Compositions and methods to reduce mutagenesis. U.S. patent US 2009/0136518 A1.
79. Singleton SF. May 2012. Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens. U.S. patent US 2012/0135092 A1.
80. Cirz RT, Chin JK, Andes DR, de Crecy-Lagard V, Craig WA, Romesberg FE. 2005. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 3:e176.
81. Lee AM, Ross CT, Zeng BB, Singleton SF. 2005. A molecular target for suppression of the evolution of antibiotic resistance: inhibition of the Escherichia coli RecA protein by N(6)-(1-naphthyl)-ADP. J. Med. Chem. 48:5408-5411.
82. Thi TD, Lopez E, Rodriguez-Rojas A, Rodriguez-Beltran J, Couce A, Guelfo JR, Castaneda-Garcia A, Blazquez J. 2011. Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials. J. Antimicrob. Chemother. 66:531-538.